Title | Type | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | %Female (2020) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Medicinal Chemistry | journal | 0.934 Q2 | 202 | 382 | 1048 | 47291 | 4223 | 959 | 3.80 | 123.80 | 47.17 | |
2 | Current Drug Targets | journal | 0.826 Q2 | 119 | 141 | 450 | 15650 | 1540 | 422 | 3.15 | 110.99 | 40.00 | |
3 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.508 Q3 | 108 | 231 | 590 | 14800 | 1433 | 572 | 2.31 | 64.07 | 41.05 | |
4 | Mini-Reviews in Medicinal Chemistry | journal | 0.603 Q3 | 107 | 149 | 359 | 14217 | 1277 | 339 | 3.65 | 95.42 | 42.91 | |
5 | Current Cancer Drug Targets | journal | 0.972 Q3 | 103 | 75 | 237 | 5949 | 734 | 219 | 3.13 | 79.32 | 38.95 | |
6 | Current Protein and Peptide Science | journal | 0.750 Q2 | 96 | 106 | 361 | 10103 | 947 | 326 | 2.75 | 95.31 | 39.79 | |
7 | Current Gene Therapy | journal | 0.704 Q3 | 80 | 38 | 129 | 2994 | 406 | 113 | 3.25 | 78.79 | 44.16 | |
8 | Current Genomics | journal | 0.823 Q3 | 77 | 64 | 172 | 4501 | 462 | 152 | 2.04 | 70.33 | 38.93 | |
9 | Current Diabetes Reviews | journal | 0.631 Q3 | 68 | 111 | 177 | 7003 | 462 | 167 | 2.21 | 63.09 | 38.63 | |
10 | Infectious Disorders - Drug Targets | journal | 0.322 Q4 | 61 | 122 | 116 | 4449 | 166 | 112 | 1.47 | 36.47 | 44.14 | |
11 | Current Organic Synthesis | journal | 0.292 Q4 | 55 | 68 | 263 | 2831 | 496 | 255 | 1.92 | 41.63 | 39.81 | |
12 | Current Nanoscience | journal | 0.285 Q3 | 52 | 88 | 212 | 6490 | 351 | 203 | 1.74 | 73.75 | 33.14 | |
13 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.710 Q3 | 52 | 26 | 89 | 2460 | 300 | 85 | 3.84 | 94.62 | 33.94 | |
14 | Current Molecular Pharmacology | journal | 0.717 Q3 | 49 | 32 | 89 | 2336 | 258 | 81 | 3.21 | 73.00 | 44.76 | |
15 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.365 Q4 | 45 | 41 | 86 | 1604 | 141 | 81 | 1.64 | 39.12 | 36.49 | |
16 | Current Aging Science | journal | 0.495 Q3 | 42 | 20 | 79 | 1269 | 170 | 74 | 1.85 | 63.45 | 60.66 | |
17 | Recent Patents on Biotechnology | journal | 0.310 Q3 | 42 | 26 | 73 | 1188 | 120 | 66 | 1.56 | 45.69 | 38.18 | |
18 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.427 Q4 | 39 | 20 | 72 | 1147 | 141 | 67 | 2.14 | 57.35 | 39.19 | |
19 | Current Bioinformatics | journal | 0.306 Q4 | 38 | 116 | 206 | 6169 | 482 | 192 | 2.82 | 53.18 | 38.75 | |
20 | Letters in Drug Design and Discovery | journal | 0.223 Q4 | 37 | 144 | 426 | 5796 | 461 | 413 | 1.11 | 40.25 | 38.05 | |
21 | Letters in Organic Chemistry | journal | 0.180 Q4 | 33 | 122 | 394 | 4278 | 324 | 373 | 0.75 | 35.07 | 28.87 | |
22 | Current Computer-Aided Drug Design | journal | 0.226 Q4 | 32 | 73 | 111 | 3171 | 129 | 99 | 1.36 | 43.44 | 36.29 | |
23 | Drug Metabolism Letters | journal | 0.302 Q4 | 31 | 0 | 53 | 0 | 59 | 45 | 1.32 | 0.00 | 0.00 | |
24 | Current Pharmaceutical Analysis | journal | 0.210 Q4 | 27 | 137 | 241 | 5109 | 206 | 239 | 0.86 | 37.29 | 44.26 | |
25 | Current Proteomics | journal | 0.213 Q4 | 27 | 41 | 127 | 2487 | 113 | 118 | 0.82 | 60.66 | 36.99 | |
26 | Current Chemical Biology | journal | 0.155 Q4 | 26 | 26 | 59 | 1269 | 45 | 54 | 0.67 | 48.81 | 29.13 | |
27 | Open Medicinal Chemistry Journal | journal | 0.294 Q4 | 23 | 12 | 33 | 758 | 63 | 31 | 1.61 | 63.17 | 48.08 | |
28 | Current Signal Transduction Therapy | journal | 0.128 Q4 | 22 | 30 | 51 | 1212 | 62 | 45 | 1.43 | 40.40 | 25.53 | |
29 | Current Pharmacogenomics and Personalized Medicine | journal | 0.264 Q4 | 20 | 24 | 37 | 969 | 35 | 33 | 1.24 | 40.38 | 48.57 | |
30 | Current Enzyme Inhibition | journal | 0.157 Q4 | 19 | 24 | 61 | 1475 | 27 | 56 | 0.40 | 61.46 | 31.15 | |
31 | Open Biotechnology Journal | journal | 0.308 Q3 | 18 | 16 | 57 | 935 | 95 | 55 | 1.83 | 58.44 | 36.84 | |
32 | Current Cancer Therapy Reviews | journal | 0.128 Q4 | 17 | 34 | 51 | 2240 | 19 | 44 | 0.28 | 65.88 | 38.28 | |
33 | Open Biomarkers Journal | journal | 0.184 Q4 | 7 | 8 | 15 | 305 | 9 | 15 | 0.60 | 38.13 | 58.70 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®